Comparing fixation location and stability in patients with neovascular age-related macular degeneration treated with or without Ranibizumab

Eye

Volumn 25, Issue 2, 2011, Pages 149-153

  Pearce, E ^a   Sivaprasad, S ^a   Chong, N V ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

age related macular degeneration; eccentric; fixation; low vision; ranibizumab; visual rehabilitation

Indexed keywords

RANIBIZUMAB;

ADULT; ARTICLE; CONTROLLED STUDY; EYE FIXATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; RETINA MACULA DEGENERATION; RETINA NEOVASCULARIZATION; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

EID: 79951574709     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2010.167     Document Type: Article

References (16)

1. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al., MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355(14): 1419-1431. (Pubitemid 44511557)
2. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al., ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006; 355(14): 1432-1444. (Pubitemid 44511558)
3. Fujii GY, De Juan Jr E, Humayun MS, Sunness JS, Chang TS, Rossi JV. Characteristics of visual loss by scanning laser ophthalmoscope microperimetry eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol 2003; 136(6): 1067-1078. (Pubitemid 37485773)
4. Crossland MD, Dunbar HM, Rubin GS. Fixation stability measurement using the MP1 microperimeter. Retina 2009; 29(5): 651-656.
5. Preacher KJ. Calculation for the chi-square test: An interactive calculation tool for chi-square tests of goodness of fit and independence (Computer software). Available fromhttp://www.quantpsy.org, 2001.
6. Framme C, Panagakis G, Birngruber R. Invest Ophthalmol Vis Sci 2010; 51(3): 1671-1676.
7. Witkin AJ, Vuong LN, Srinivasan VJ, Gorczynska I, Reichel E, Baumal CR et al. High-speed ultrahigh resolution optical coherence tomography before and after ranibizumab for age-related macular degeneration. Ophthalmology 2009; 116(5): 956-963.
8. Green WR, Enger C. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology 1993; 100: 1519-1535. (Pubitemid 23292863)
9. Timberlake GT, Peli E, Essock EA, Augliere RA. Reading with a macular scotoma: II. Retinal locus for scanning text. Invest Ophthalmol Vis Sci 1987; 28: 1268.
10. Crossland MD, Culham LE, Kabanarou SA, Rubin GS. Preferred retinal locus development in patients with macular disease. Ophthalmology 2005; 112(9): 1579-1585. (Pubitemid 41725416)
11. Palmer S, Logan D, Nabili S, Dutton GN. Br J Ophthalmol 2010; 94(4): 494-497.
12. Fornos AP, Sommerhalder J, Rappaz B, Pelizzone M, Safran AB. Processes involved in oculomotor adaptation to eccentric reading. Invest Ophthalmol Vis Sci 2006; 47(4): 1439-1447. (Pubitemid 46780750)
13. Stelmack JA, Massof RW, Stelmack TR. Is there a standard of care for eccentric viewing training? J Rehabil Res Dev 2004; 41(5): 729-738. (Pubitemid 39507458)
14. Nilsson UL, Frennesson C, Nilsson SE. Patients with AMD and a large absolute central scotoma can be trained successfully to use eccentric viewing, as demonstrated in a scanning laser ophthalmoscope. Vision Res 2003; 43(16): 1777-1787. (Pubitemid 36724814)
15. Goodrich GL, Mehr EB. Eccentric viewing training and low vision aids: current practice and implications of peripheral retinal research. Am J Optom Physiol Opt 1986; 63(2): 119-126. (Pubitemid 16128462)
16. Stelmack JA, Massof RW, Stelmack TR. Is there a standard of care for eccentric viewing training? J Rehabil Res Dev 2004; 41(5): 729-738. (Pubitemid 39507458)